PURPOSE: This study aimed to evaluate whether the Fischer score criteria on contrast-enhanced magnetic resonance (CE-MR) imaging could correlate with histopathological prognostic factors in invasive breast cancer. MATERIALS AND METHODS: Seventy-two women with histologically proven invasive breast cancer underwent preoperative CE-MR imaging. Images were assessed for the following parameters, according to the scoring system described by Fischer in 1999: tumour shape, margins, internal enhancement, signal intensity increase, signal intensity course and overall Fischer score. Evaluated histopathological prognostic factors included histological type, associated extensive intraductal component, diameter, lymph node metastasis, tumour grade, and oestrogen receptor (ER), progesterone receptor (PgR), Ki67 proliferation, oncogene c-erbB-2 (HER2/neu) expression. Fisher's exact test was used to correlate the CE-MR imaging parameters and histopathological findings (with significance set a p < 0.05). RESULTS: Fischer's score was 0-4 in 14/72 (19%) cases, >4 in 58/72 (81%) and 3 in 5/72 (7%; false negative), with a sensitivity of 93%. A significant correlation (p=0.02) was found between stellate-dendritic shape and the presence of an associated extensive intraductal component (EIC), which was found in 78% of stellate tumours vs. 49% of round-oval tumours. A significant correlation (p=0.039) was found between Ki67 expression and signal intensity course (Ki67 overexpression was present in 81% of tumours with washout course vs. 21% with plateau course). CONCLUSIONS: The CE-MR imaging findings that correlate with prognostic factors are shape and signal intensity curve. Fischer's multifactorial analysis was helpful in the interpretation of CE-MR images, showing a sensitivity of 93% for invasive breast cancer.
PURPOSE: This study aimed to evaluate whether the Fischer score criteria on contrast-enhanced magnetic resonance (CE-MR) imaging could correlate with histopathological prognostic factors in invasive breast cancer. MATERIALS AND METHODS: Seventy-two women with histologically proven invasive breast cancer underwent preoperative CE-MR imaging. Images were assessed for the following parameters, according to the scoring system described by Fischer in 1999: tumour shape, margins, internal enhancement, signal intensity increase, signal intensity course and overall Fischer score. Evaluated histopathological prognostic factors included histological type, associated extensive intraductal component, diameter, lymph node metastasis, tumour grade, and oestrogen receptor (ER), progesterone receptor (PgR), Ki67 proliferation, oncogene c-erbB-2 (HER2/neu) expression. Fisher's exact test was used to correlate the CE-MR imaging parameters and histopathological findings (with significance set a p < 0.05). RESULTS: Fischer's score was 0-4 in 14/72 (19%) cases, >4 in 58/72 (81%) and 3 in 5/72 (7%; false negative), with a sensitivity of 93%. A significant correlation (p=0.02) was found between stellate-dendritic shape and the presence of an associated extensive intraductal component (EIC), which was found in 78% of stellate tumours vs. 49% of round-oval tumours. A significant correlation (p=0.039) was found between Ki67 expression and signal intensity course (Ki67 overexpression was present in 81% of tumours with washout course vs. 21% with plateau course). CONCLUSIONS: The CE-MR imaging findings that correlate with prognostic factors are shape and signal intensity curve. Fischer's multifactorial analysis was helpful in the interpretation of CE-MR images, showing a sensitivity of 93% for invasive breast cancer.
Authors: F Sardanelli; G M Giuseppetti; G Canavese; L Cataliotti; S Corcione; E Cossu; M Federico; L Marotti; L Martincich; P Panizza; F Podo; M Rosselli Del Turco; C Zuiani; C Alfano; M Bazzocchi; P Belli; S Bianchi; A Cilotti; M Calabrese; L Carbonaro; L Cortesi; C Di Maggio; A Del Maschio; A Esseridou; A Fausto; M Gennaro; R Girometti; R Ienzi; A Luini; S Manoukian; S Morassutt; D Morrone; J Nori; A Orlacchio; F Pane; P Panzarola; R Ponzone; G Simonetti; P Torricelli; G Valeri Journal: Radiol Med Date: 2008-10-16 Impact factor: 3.469
Authors: L D Buadu; J Murakami; S Murayama; N Hashiguchi; S Sakai; S Toyoshima; K Masuda; S Kuroki; S Ohno Journal: J Comput Assist Tomogr Date: 1997 May-Jun Impact factor: 1.826
Authors: P C Stomper; S Herman; D L Klippenstein; J S Winston; S B Edge; M A Arredondo; R V Mazurchuk; L E Blumenson Journal: Radiology Date: 1995-11 Impact factor: 11.105
Authors: Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber Journal: N Engl J Med Date: 2005-10-20 Impact factor: 91.245
Authors: G Carbognin; V Girardi; C Calciolari; A Brandalise; F Bonetti; A Russo; R Pozzi Mucelli Journal: Radiol Med Date: 2010-06-23 Impact factor: 3.469
Authors: Jamal J Derakhshan; Elizabeth S McDonald; Evan S Siegelman; Mitchell D Schnall; Felix W Wehrli Journal: Magn Reson Med Date: 2017-08-24 Impact factor: 4.668
Authors: Susanne Wienbeck; Uwe Fischer; Christina Perske; Andreas Wienke; Hans Jonas Meyer; Joachim Lotz; Alexey Surov Journal: Transl Oncol Date: 2017-06-27 Impact factor: 4.243